Variant report

Variant	nsv1053585
Chromosome Location	chr11:63057767-63180308
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:225)
CpG islands
(count:671)
Chromatin interactive
region (count:11)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:225 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:63057050-63057851	HepG2	liver:	n/a	n/a
2	ARID3A	chr11:63129959-63130192	HepG2	liver:	n/a	n/a
3	ARID3A	chr11:63172034-63172387	HepG2	liver:	n/a	n/a
4	ARID3A	chr11:63058059-63058071	HepG2	liver:	n/a	n/a
5	ARID3A	chr11:63136377-63137349	HepG2	liver:	n/a	chr11:63137038-63137054
6	ATF1	chr11:63094842-63094868	K562	blood:	n/a	n/a
7	BRCA1	chr11:63137380-63137560	HepG2	liver:	n/a	n/a
8	CEBPB	chr11:63089047-63089257	A549	lung:	n/a	chr11:63089164-63089175
9	CEBPB	chr11:63176003-63176089	HepG2	liver:	n/a	chr11:63176030-63176041
10	CEBPB	chr11:63136341-63136879	HepG2	liver:	n/a	chr11:63136515-63136526
11	CEBPB	chr11:63089035-63089313	HepG2	liver:	n/a	chr11:63089164-63089175
12	CEBPB	chr11:63136436-63136636	A549	lung:	n/a	chr11:63136515-63136526
13	CEBPB	chr11:63136350-63136649	IMR90	lung:	n/a	chr11:63136515-63136526
14	CEBPB	chr11:63129942-63130317	HepG2	liver:	n/a	chr11:63130119-63130130
15	CEBPB	chr11:63172068-63172472	HepG2	liver:	n/a	n/a
16	CEBPB	chr11:63129984-63130189	HepG2	liver:	n/a	chr11:63130119-63130130
17	CEBPB	chr11:63136413-63136622	K562	blood:	n/a	chr11:63136515-63136526
18	CEBPB	chr11:63171995-63172370	HepG2	liver:	n/a	n/a
19	CEBPB	chr11:63070914-63071095	HepG2	liver:	n/a	n/a
20	CEBPB	chr11:63172022-63172347	HepG2	liver:	n/a	n/a
21	CEBPB	chr11:63172016-63172462	HepG2	liver:	n/a	n/a
22	CEBPB	chr11:63129927-63130249	HepG2	liver:	n/a	chr11:63130119-63130130
23	CEBPB	chr11:63138949-63139248	HepG2	liver:	n/a	n/a
24	CEBPB	chr11:63130023-63130223	A549	lung:	n/a	chr11:63130119-63130130
25	CEBPB	chr11:63130096-63130141	Hela-S3	cervix:	n/a	chr11:63130119-63130130
26	CEBPB	chr11:63129930-63130293	HepG2	liver:	n/a	chr11:63130119-63130130
27	CEBPD	chr11:63172037-63172382	HepG2	liver:	n/a	n/a
28	CEBPD	chr11:63129997-63130250	HepG2	liver:	n/a	n/a
29	CTCF	chr11:63144320-63144470	MCF-7	breast:	n/a	n/a
30	CTCF	chr11:63110773-63110885	Pancreas_OC	pancreas:	n/a	n/a
31	CTCF	chr11:63110785-63110864	MCF-7	breast:	n/a	n/a
32	CTCF	chr11:63063580-63063730	GM12869	blood:	n/a	n/a
33	CTCF	chr11:63110820-63110970	MCF-7	breast:	n/a	n/a
34	CTCF	chr11:63172140-63172290	GM12867	blood:	n/a	n/a
35	CTCF	chr11:63104900-63105050	GM12864	blood:	n/a	n/a
36	CTCF	chr11:63174907-63174966	K562	blood:	n/a	n/a
37	CTCF	chr11:63110781-63110893	Hela-S3	cervix:	n/a	n/a
38	CTCF	chr11:63077941-63077951	GM10248	blood:	n/a	n/a
39	CTCF	chr11:63116589-63116660	Lung_OC	lung:	n/a	n/a
40	CTCF	chr11:63144880-63145030	GM12872	blood:	n/a	n/a
41	CTCF	chr11:63156987-63157069	LNCaP	prostate:	n/a	n/a
42	CTCF	chr11:63144300-63144450	MCF-7	breast:	n/a	n/a
43	CTCF	chr11:63162079-63162147	Lung_OC	lung:	n/a	n/a
44	CTCF	chr11:63144300-63144450	HRE	kidney:	n/a	n/a
45	CTCF	chr11:63137700-63137850	Caco-2	colon:	n/a	n/a
46	CTCF	chr11:63144200-63144350	Caco-2	colon:	n/a	n/a
47	CTCF	chr11:63144266-63144337	LNCaP	prostate:	n/a	n/a
48	CTCF	chr11:63156915-63156980	LNCaP	prostate:	n/a	n/a
49	CTCF	chr11:63144220-63144370	Hela-S3	cervix:	n/a	n/a
50	CTCF	chr11:63110780-63110930	HCT-116	colon:	n/a	n/a

(count:671 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:63136414-63136464	SAEC	small airway:	n/a
2	chr11:63137152-63137202	HAEpiC	amniotic membrane:	n/a
3	chr11:63080490-63080540	AoSMC	blood vessel:	n/a
4	chr11:63080490-63080540	AG10803	skin:	n/a
5	chr11:63136414-63136464	RPTEC	kidney:	n/a
6	chr11:63177356-63177406	GM12891	blood:	n/a
7	chr11:63136783-63136833	NHBE	bronchial:	n/a
8	chr11:63137398-63137448	ovcar-3	ovarian:	n/a
9	chr11:63136414-63136464	Hela-S3	cervix:	n/a
10	chr11:63080490-63080540	Caco-2	colon:	n/a
11	chr11:63136414-63136464	CMK	blood:	n/a
12	chr11:63177356-63177406	NT2-D1	testis:	n/a
13	chr11:63140804-63140854	PFSK-1	brain:	n/a
14	chr11:63137555-63137605	SKMC	muscle:	n/a
15	chr11:63137152-63137202	PFSK-1	brain:	n/a
16	chr11:63137125-63137175	GM12878	blood:	n/a
17	chr11:63177356-63177406	HPAEpiC	pulmonary alveolar:	n/a
18	chr11:63137398-63137448	NH-A	brain:	n/a
19	chr11:63066471-63066521	Hela-S3	cervix:	n/a
20	chr11:63136783-63136833	GM19239	blood:	n/a
21	chr11:63080472-63080522	MCF-7	breast:	n/a
22	chr11:63177356-63177406	BJ	skin:	n/a
23	chr11:63177356-63177406	PANC-1	pancreas:	n/a
24	chr11:63080490-63080540	SKMC	muscle:	n/a
25	chr11:63137152-63137202	SKMC	muscle:	n/a
26	chr11:63177356-63177406	HMEC	breast:	n/a
27	chr11:63137555-63137605	HEK293	kidney:	embryo
28	chr11:63137398-63137448	HPAEpiC	pulmonary alveolar:	n/a
29	chr11:63140804-63140854	AG04449	skin:	fetal
30	chr11:63137555-63137605	NHDF-neo	bronchial:	n/a
31	chr11:63080490-63080540	GM06990	blood:	n/a
32	chr11:63080472-63080522	Hepatocyte	liver:	n/a
33	chr11:63140804-63140854	ovcar-3	ovarian:	n/a
34	chr11:63140804-63140854	HIPEpiC	eye:	n/a
35	chr11:63137152-63137202	HMEC	breast:	n/a
36	chr11:63136414-63136464	Caco-2	colon:	n/a
37	chr11:63137398-63137448	BJ	skin:	n/a
38	chr11:63136783-63136833	NT2-D1	testis:	n/a
39	chr11:63136783-63136833	PFSK-1	brain:	n/a
40	chr11:63137125-63137175	HUVEC	blood vessel:	n/a
41	chr11:63080472-63080522	HPAEpiC	pulmonary alveolar:	n/a
42	chr11:63137555-63137605	AoSMC	blood vessel:	n/a
43	chr11:63136414-63136464	ProgFib	skin:	n/a
44	chr11:63136414-63136464	BE2_C	brain:	n/a
45	chr11:63137398-63137448	HNPCEpiC	eye:	n/a
46	chr11:63080472-63080522	HAEpiC	amniotic membrane:	n/a
47	chr11:63066471-63066521	AoSMC	blood vessel:	n/a
48	chr11:63137398-63137448	HRE	kidney:	n/a
49	chr11:63177356-63177406	HAEpiC	amniotic membrane:	n/a
50	chr11:63136414-63136464	U87	brain:	n/a

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:63057865..63060126-chr11:63074539..63077166,2	MCF-7	breast:
2	chr11:63057865..63060126-chr11:63074539..63077166,2	MCF-7	breast:
3	chr11:63143315..63147514-chr11:63148756..63151985,3	K562	blood:
4	chr11:63103438..63104964-chr14:78144218..78145718,2	MCF-7	breast:
5	chr11:63072177..63073810-chr11:63074201..63076770,2	MCF-7	breast:
6	chr11:63065508..63067181-chr11:63068021..63070968,2	MCF-7	breast:
7	chr11:63072177..63073810-chr11:63074201..63076770,2	MCF-7	breast:
8	chr11:63065508..63067181-chr11:63068021..63070968,2	MCF-7	breast:
9	chr11:63136269..63139132-chr11:63142278..63145159,2	MCF-7	breast:
10	chr11:63168551..63171520-chr3:13164041..13166803,2	MCF-7	breast:
11	chr11:63143315..63147514-chr11:63148756..63151985,3	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLC22A9-1	chr11:63090923-63092662	l_488_chr11:63090922-63093361_brain
2	lnc-HRASLS5-3	chr11:63148132-63151901	ucscGeneNc_uc001nxj_1
3	lnc-SLC22A9-1	chr11:63093324-63095856	l_488_chr11:63090922-63093361_brain

No data

Variant related genes	Relation type
SLC22A9	TF binding region
SLC22A10	TF binding region
SLC22A9	CpG island
SLC22A10	CpG island
ENSG00000149742	chromatin interactions

Extended variants
information (count: 3551 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:3551 , 50 per page) page: 1 2 3 4 5 6 7 ... 72

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs374307478	chr11:63057780-63057781	Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs199571339	chr11:63057790-63057791	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs375827630	chr11:63057817-63057818	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs202137645	chr11:63057844-63057845	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs75844061	chr11:63057846-63057847	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs370636623	chr11:63057848-63057849	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs537450056	chr11:63057849-63057850	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs201296658	chr11:63057855-63057856	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs200472969	chr11:63057876-63057877	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs374301548	chr11:63057898-63057899	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs142941660	chr11:63057903-63057904	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs372717316	chr11:63057906-63057907	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs376009616	chr11:63057917-63057918	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs1790218	chr11:63057925-63057926	Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs372255161	chr11:63057926-63057927	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs375285973	chr11:63057927-63057928	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs114974500	chr11:63057938-63057939	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs377088527	chr11:63057945-63057946	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs558797692	chr11:63057978-63057979	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs75556887	chr11:63057994-63057995	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs369444855	chr11:63057998-63057999	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs575865335	chr11:63058003-63058004	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs371829766	chr11:63058011-63058012	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs375815673	chr11:63058015-63058016	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs201514423	chr11:63058024-63058025	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs200731936	chr11:63058030-63058031	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs369081128	chr11:63058047-63058048	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs147004229	chr11:63058060-63058061	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs372658221	chr11:63058063-63058064	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs191860104	chr11:63058068-63058069	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs118040658	chr11:63058088-63058089	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs183943740	chr11:63058094-63058095	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs188397670	chr11:63058104-63058105	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs192120438	chr11:63058111-63058112	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs528736980	chr11:63058115-63058116	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs374337585	chr11:63058159-63058160	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs150539648	chr11:63058199-63058200	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs548757928	chr11:63058236-63058237	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs3019069	chr11:63058326-63058327	Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs486460	chr11:63058337-63058338	Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
41	rs376637629	chr11:63058352-63058353	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs576877729	chr11:63058392-63058393	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs570788590	chr11:63058394-63058395	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs559589804	chr11:63058416-63058417	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs143644686	chr11:63058438-63058439	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs374100639	chr11:63058439-63058440	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs558623801	chr11:63058460-63058461	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs573493455	chr11:63058462-63058463	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs565626816	chr11:63058469-63058470	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs184244508	chr11:63058503-63058504	Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Colorectal cancer	16272173	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Pituitary adenoma	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	21080181	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelofibrosis	22110671	CNVD
Metanephric adenoma	20802469	CNVD
Chordoma	21602918	CNVD
Melanoma	18172304	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21785460	CNVD
Breast cancer	20409316	CNVD
Spinal muscular atrophy	17160897	CNVD
Retinitis pigmentosa	17160897	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	16417655	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	17217626	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	21045282	CNVD
Breast cancer	21806811	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD

Chromatin state (count:94 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:63056400-63059200	Enhancers	HepG2	liver
2	chr11:63057200-63060600	Active TSS	Liver	Liver
3	chr11:63058800-63059600	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr11:63060600-63061000	Flanking Active TSS	Liver	Liver
5	chr11:63061000-63061200	Enhancers	Liver	Liver
6	chr11:63061200-63061600	Weak transcription	Liver	Liver
7	chr11:63061600-63061800	Active TSS	Liver	Liver
8	chr11:63061800-63062000	Flanking Active TSS	Liver	Liver
9	chr11:63062000-63062600	Active TSS	Liver	Liver
10	chr11:63062600-63062800	Flanking Active TSS	Liver	Liver
11	chr11:63062800-63063000	Enhancers	Liver	Liver
12	chr11:63063000-63064400	Genic enhancers	Liver	Liver
13	chr11:63064400-63076000	Strong transcription	Liver	Liver
14	chr11:63074800-63075000	Bivalent/Poised TSS	Primary hematopoietic stem cells	blood
15	chr11:63076000-63081000	ZNF genes & repeats	Liver	Liver
16	chr11:63127400-63127600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr11:63127600-63128600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr11:63128400-63130400	Enhancers	Adipose Nuclei	Adipose
19	chr11:63128600-63128800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
20	chr11:63128800-63129800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr11:63129600-63130600	Enhancers	HepG2	liver
22	chr11:63129800-63130000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr11:63129800-63130400	Enhancers	Fetal Intestine Small	intestine
24	chr11:63130800-63131200	Weak transcription	HepG2	liver
25	chr11:63135600-63136200	Weak transcription	HepG2	liver
26	chr11:63136200-63136400	Enhancers	HepG2	liver
27	chr11:63136400-63136600	Enhancers	Liver	Liver
28	chr11:63136400-63137200	Flanking Active TSS	HepG2	liver
29	chr11:63136600-63137000	Flanking Active TSS	Liver	Liver
30	chr11:63137000-63137600	Active TSS	Liver	Liver
31	chr11:63137200-63137400	Active TSS	HepG2	liver
32	chr11:63137200-63137600	Enhancers	Fetal Intestine Large	intestine
33	chr11:63137200-63137600	Enhancers	Rectal Mucosa Donor 31	rectum
34	chr11:63137200-63138000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
35	chr11:63137400-63137600	Flanking Active TSS	HepG2	liver
36	chr11:63137400-63137800	Enhancers	Spleen	Spleen
37	chr11:63137400-63138000	Enhancers	Pancreas	Pancrea
38	chr11:63137600-63138200	Flanking Active TSS	Liver	Liver
39	chr11:63137600-63138200	Flanking Bivalent TSS/Enh	HepG2	liver
40	chr11:63137800-63138000	Enhancers	Gastric	stomach
41	chr11:63138000-63141000	Weak transcription	Pancreas	Pancrea
42	chr11:63138200-63138800	Active TSS	Liver	Liver
43	chr11:63138200-63139600	Flanking Active TSS	HepG2	liver
44	chr11:63138800-63139000	Flanking Active TSS	Liver	Liver
45	chr11:63139000-63139200	Active TSS	Liver	Liver
46	chr11:63139200-63139800	Flanking Active TSS	Liver	Liver
47	chr11:63139600-63139800	Active TSS	HepG2	liver
48	chr11:63139800-63140200	Weak transcription	HepG2	liver
49	chr11:63139800-63141800	Enhancers	Liver	Liver
50	chr11:63140200-63141400	Enhancers	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links